Related references
Note: Only part of the references are listed.Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons
Joonhong Jun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer's Disease: Investigating Structure through Docking Studies
Hyunwook Cho et al.
BIOMEDICINES (2021)
Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1H)-Carboxamide as a Novel JNK Inhibitor
Miyoung Jang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay
Ravi Kumar Rajan et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2020)
Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3
Youri Oh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors
Xiaodong Dou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
被撤回的出版物: Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats (Retracted article. See vol. 15, pg. 6069, 2022)
Zikra Zulfiqar et al.
JOURNAL OF INFLAMMATION RESEARCH (2020)
Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods
Ghada Omar Tuffaha et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Multistage Screening Reveals 3-Substituted lndolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases
Xiaodong Dou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Inhibition of c-Jun N-Terminal Kinase Activation Reverses Alzheimer Disease Phenotypes in APPswe/PS1dE9 Mice
Qiong Zhou et al.
ANNALS OF NEUROLOGY (2015)
Permeability of the Blood-Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds
Clifford W. Fong
JOURNAL OF MEMBRANE BIOLOGY (2015)
Molecular determinants of blood-brain barrier permeation
Werner J. Geldenhuys et al.
THERAPEUTIC DELIVERY (2015)
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
Ke Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects
Mi-hyun Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
JNK inhibitors as anti-inflammatory and neuroprotective agents
Piotr P. Graczyk
FUTURE MEDICINAL CHEMISTRY (2013)
Chemoselective Reactions of 4,6-Dichloro-2-(methylsulfonyl)pyrimidine and Related Electrophiles with Amines
Ramil Baiazitov et al.
SYNTHESIS-STUTTGART (2013)
JNK3 Perpetuates Metabolic Stress Induced by Aβ Peptides
Sung Ok Yoon et al.
NEURON (2012)
Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's Disease
Jeremy W. Chambers et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability
Jurgen Mensch et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
JNK regulates APP cleavage and degradation in a model of Alzheimer's disease
Alessio Colombo et al.
NEUROBIOLOGY OF DISEASE (2009)
Development of in vitro pharmacokinetic screens using Caco-2, human hepatocyte, and Caco-2/Human hepatocyte hybrid systems for the prediction of oral bioavailability in humans
Cheng Li et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice
Jenna C. Carroll et al.
JOURNAL OF NEUROSCIENCE (2007)
The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease
Gary L. Johnson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice
M. X. Ma et al.
NEUROSCIENCE (2007)
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2006)
Exploration of a binding mode of benzothiazol-2-yl acetonitrile pyrimidine core based derivatives as potent c-Jun N-terminal kinase-3 inhibitors and 3D-QSAR analyses
Pooja Sharma et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity
Bruce G. Szczepankiewicz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of e-Jun N-terminal kinase-3
BM Swahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons:: involvement of protein kinase C
YS Han et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease
WY Wang et al.
NEUROSCIENCE RESEARCH (2004)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
